Login / Signup

Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.

Kathryn M HastieHaoyang LiDaniel H BedingerSharon L SchendelS Moses DennisonKan LiVamseedhar RayaproluXiaoying YuColin J MannMichelle A ZandonattiRuben Diaz AvalosDawid S ŻyłaTierra BuckSean HuiKelly ShafferChitra HariharanJieyun YinEduardo OlmedillasAdrian S EnriquezDiptiben ParekhMilite AbrahaElizabeth FeeneyGillian Q Hornnull nullYoann AldonHanif AliSanja AracicRonald R CobbRoss S FedermanJoseph M FernandezJacob GlanvilleRobin GreenGevorg GrigoryanAna G Lujan HernandezDavid D HoKuan-Ying A HuangJohn IngrahamWeidong JiangPaul KellamCheolmin KimMinsoo KimHyeong Mi KimChao KongShelly J KrebsFei LanGuojun LangSoo-Young LeeCheuk Lun LeungJunli LiuYanan LuAnna J MacCamyAndrew T McGuireAnne L PalserTerence Howard RabbittsZahra R TehraniMohammad M SajadiRogier W SandersAaron K SatoLiang SchweizerJi-Min SeoBingqing ShenJonne L SnitselaarLeonidas StamatatosYongcong TanMilan T TomicMarit J VAN GilsSawsan YoussefJian YuTom Z YuanQian ZhangBjoern PetersGeorgia D TomarasTimothy GermannErica Ollmann Saphire
Published in: Science (New York, N.Y.) (2021)
[Figure: see text].
Keyphrases
  • sars cov
  • cancer therapy
  • respiratory syndrome coronavirus
  • smoking cessation
  • drug delivery